Fri Feb 1, 2013 8:25am EST
(Reuters) - Generic drugmaker Perrigo Co (PRGO.O) reported a better-than-expected second-quarter profit and said it would buy pet health products maker Velcera Inc for $160 million to beef up its animal healthcare business.
Perrigo's shares rose 3 percent to $103.50 in premarket trade.
The Allegan, Michigan-based company said second-quarter results were helped by a 14 percent rise in sales in its consumer healthcare business.
Net income rose 6 percent to $105.9 million, or $1.12 per share. Revenue rose 5 percent to $882.9 million.
Excluding items, the company earned $1.36 per share.
Analysts expected earnings of $1.31 per share on revenue of $880.8 million, according to Thomson Reuters I/B/E/S.
0 comments:
Post a Comment